These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 29685393)

  • 1. Notification and counselling of hepatitis positive blood donors, their immediate emotional response, contact-testing and their follow-up: Study from a tertiary care hospital!
    Tiwari AK; Bhardwaj G; Dara RC; Arora D; Aggarwal G; Bhargava R; Madan K
    Transfus Apher Sci; 2018 Jun; 57(3):391-397. PubMed ID: 29685393
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence & significance of hepatitis C virus (HCV) seropositivity in blood donors.
    Thakral B; Marwaha N; Chawla YK; Saluja K; Sharma A; Sharma RR; Minz RW; Agnihotri SK
    Indian J Med Res; 2006 Oct; 124(4):431-8. PubMed ID: 17159264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Seroprevalence of transfusion transmitted infection among blood donors at Jijiga blood bank, Eastern Ethiopia: retrospective 4 years study.
    Mohammed Y; Bekele A
    BMC Res Notes; 2016 Feb; 9():129. PubMed ID: 26922241
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Blood donor notification and counseling: Our experience from a tertiary care hospital in India.
    Kotwal U; Doda V; Arora S; Bhardwaj S
    Asian J Transfus Sci; 2015; 9(1):18-22. PubMed ID: 25722567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk factors for hepatitis C virus infection among blood donors in northern Thailand.
    Thaikruea L; Thongsawat S; Maneekarn N; Netski D; Thomas DL; Nelson KE
    Transfusion; 2004 Oct; 44(10):1433-40. PubMed ID: 15383015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk factors for hepatitis B and C infection among blood donors in five Chinese blood centers.
    Huang Y; Guo N; Yu Q; Lv Y; Ma H; Yun Z; Yao F; Dong X; Zhu X; Wen X; Cao R; Huang M; Bi X; Zhao M; Tiemuer MH; Li J; Zhou Z; He W; Liu J; Wright DJ; Wang J; Ness P; Shan H;
    Transfusion; 2015 Feb; 55(2):388-94. PubMed ID: 25382751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The persistence of hepatitis C virus transmission risk in China despite serologic screening of blood donations.
    Wang J; Liu J; Huang Y; Wright DJ; Li J; Zhou Z; He W; Yang T; Yao F; Zhu X; Wen G; Bi X; Tiemuer MH; Wen X; Huang M; Cao R; Yun Z; Lü Y; Ma H; Guo N; Yu Q; Ness P; Shan H;
    Transfusion; 2013 Oct; 53(10 Pt 2):2489-97. PubMed ID: 23781978
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Transfusion Transmissible Infections Elicited on Post Donation Counselling in Blood Donors: Need to Strengthen Pre-donation Counselling.
    Sachdev S; Mittal K; Patidar G; Marwaha N; Sharma RR; Duseja AK; Chawla YK; Arora SK
    Indian J Hematol Blood Transfus; 2015 Sep; 31(3):378-84. PubMed ID: 26085725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and epidemiological characteristics of hepatitis C in Scottish blood donors.
    Crawford RJ; Gillon J; Yap PL; Brookes E; McOmish F; Simmonds P; Dow BC; Follett EA
    Transfus Med; 1994 Jun; 4(2):121-4. PubMed ID: 7921048
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Confirmation and follow up of initial "NAT yields": Prospective study from a tertiary healthcare center in India.
    Pandey P; Tiwari AK; Dara RC; Rawat GS; Negi A; Raina V
    Transfus Apher Sci; 2016 Apr; 54(2):242-7. PubMed ID: 26321477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence and Trends of Transfusion-Transmissible Viral Infections among Blood Donors in South of Iran: An Eleven-Year Retrospective Study.
    Farshadpour F; Taherkhani R; Tajbakhsh S; Gholizadeh Tangestani M; Hajiani G; Sharifi N; Taherkhani S; Nejadbolkheyr A
    PLoS One; 2016; 11(6):e0157615. PubMed ID: 27309959
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Detection of occult hepatitis B and window period infection among blood donors by individual donation nucleic acid testing in a tertiary care center in South India.
    Keechilot CS; Shenoy V; Kumar A; Biswas L; Vijayrajratnam S; Dinesh K; Nair P
    Pathog Glob Health; 2016; 110(7-8):287-291. PubMed ID: 27788631
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Deferred donor care in a regional hospital blood center in Ghana.
    Allain JP; Opare-Sem O; Sarkodie F; Rahman R; Owusu-Ofori S
    Transfusion; 2009 Apr; 49(4):669-75. PubMed ID: 19170991
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Long-term results of HBV and HCV infection in patients with blood system diseases].
    Garmaeva TTs; Kulikov SM; Mikhaĭlova EA; Gemdzhian EG; Gaponova TV; Grumbkova LO; Iaroslavtseva NG; Tupoleva TA; Somova AV; Makarik TA; Glinshchikova OA; Fevraleva IS; Sudarikov AB; Filatov FP; Savchenko VG
    Ter Arkh; 2011; 83(7):17-26. PubMed ID: 21894747
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Viremia levels in hepatitis C infection among Egyptian blood donors and implications for transmission risk with different screening scenarios.
    El Ekiaby M; Moftah F; Goubran H; van Drimmelen H; LaPerche S; Kleinman S; Busch M; Lelie N
    Transfusion; 2015 Jun; 55(6):1186-94. PubMed ID: 25766141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Response rate of blood donors in the Uttarakhand region of India after notification of reactive test results on their blood samples.
    Agarwal N
    Blood Transfus; 2014 Jan; 12 Suppl 1(Suppl 1):s51-3. PubMed ID: 24599905
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The characteristics of hepatitis B surface antigen (HBsAg)-negative hepatitis B virus (HBV) infection in Chinese blood donors: a follow-up study of donors tested negative for HBsAg and reactive for simultaneous nucleic acid testing of HBV, hepatitis C virus, and human immunodeficiency virus.
    Guo Z; Fu P; Yin Y; Wang F; Yin Y; Wang J; Liu Y
    Transfusion; 2017 Mar; 57(3pt2):832-840. PubMed ID: 28164313
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Seroepidemiological Study of Hepatitis B, C and HIV among Blood Donors in Kerman.
    Mohsenizadeh M; Mollaei HR; Ghaziizadeh M
    Asian Pac J Cancer Prev; 2017 Dec; 18(12):3267-3272. PubMed ID: 29286218
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donor notification and counseling--experience and challenges.
    Kaur G; Kaur P; Basu S; Kaur R; Sharma S
    Transfus Apher Sci; 2013 Oct; 49(2):291-4. PubMed ID: 23769171
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and estimated rates of residual risk for HIV, hepatitis C, hepatitis B and human T-cell lymphotropic viruses in blood donors in Canada, 1990-2000.
    Chiavetta JA; Escobar M; Newman A; He Y; Driezen P; Deeks S; Hone DE; O'Brien SF; Sher G
    CMAJ; 2003 Oct; 169(8):767-73. PubMed ID: 14557314
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.